Immune checkpoints and ncRNAs: pioneering immunotherapy approaches for hematological malignancies.

Autor: Anvari, Samira¹ (AUTHOR) samira.anvari68@gmail.com, Nikbakht, Mohsen² (AUTHOR) m-nikbakht@sina.tums.ac.ir, Vaezi, Mohammad³ (AUTHOR) vaezi.mohammad@yahoo.com, Amini-Kafiabad, Sedigheh¹ (AUTHOR) dr.amini@gmail.com, Ahmadvand, Mohammad² (AUTHOR) Ahmadvand.mohamad64@yahoo.com

Publikováno v: Cancer Cell International. 12/19/2024, Vol. 24 Issue 1, p1-24. 24p.

Long non-coding RNAs and enhancer RNAs regulate the lipopolysaccharide-induced inflammatory response in human monocytes

Autor: IIott, NE, Heward, JA, Roux, B, Tsitsiou, E, Fenwick, PS, Lenzi, L, Goodhead, IB, Hertz-Fowler, C, Heger, A, Hall, N, Donnelly, LE, Sims, D, Lindsay, MA

Publikováno v: Nature Communications
Ilott, N E, Heward, J A, Roux, B, Tsitsiou, E, Fenwick, P S, Lenzi, L, Goodhead, I, Hertz-Fowler, C, Heger, A, Hall, N, Donnelly, L E, Sims, D & Lindsay, M A 2014, ' Long non-coding RNAs and enhancer RNAs regulate the lipopolysaccharide-induced inflammatory response in human monocytes ', Nature Communications, vol. 5, 3979 . https://doi.org/10.1038/ncomms4979

Early reports indicate that long non-coding RNAs (lncRNAs) are novel regulators of biological responses. However, their role in the human innate immune response, which provides the initial defence against infection, is largely unexplored. To address

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::70518e01c36e2269c1a402d52a6a4dda
http://europepmc.org/articles/PMC4061460

GATA2 monoallelic expression underlies reduced penetrance in inherited GATA2-mutated MDS/AML.

Autor: Al Seraihi AF; Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, London, UK. a.f.h.alseraihi@qmul.ac.uk., Rio-Machin A; Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, London, UK., Tawana K; Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, London, UK., Bödör C; MTA-SE Lendulet Molecular Oncohematology Research Group, 1st Department of Pathology and Experimental Cancer Research, Semmelweis University, Budapest, Hungary., Wang J; Centre for Molecular Oncology, Barts Cancer Institute, Queen Mary University of London, London, UK., Nagano A; Centre for Molecular Oncology, Barts Cancer Institute, Queen Mary University of London, London, UK., Heward JA; Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, London, UK., Iqbal S; Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, London, UK., Best S; Laboratory for Molecular Haemato-Oncology, King's College Hospital NHS Foundation Trust, London, UK., Lea N; Laboratory for Molecular Haemato-Oncology, King's College Hospital NHS Foundation Trust, London, UK., McLornan D; Department of Haematological Medicine, King's College Hospital, London, UK., Kozyra EJ; University of Freiburg, Faculty of Biology, Freiburg, Germany.; Pediatric Hematology and Oncology, University Children's Hospital Freiburg, Freiburg, Germany., Wlodarski MW; Pediatric Hematology and Oncology, University Children's Hospital Freiburg, Freiburg, Germany., Niemeyer CM; Pediatric Hematology and Oncology, University Children's Hospital Freiburg, Freiburg, Germany., Scott H; Centre for Cancer Biology, SA Pathology, University of South Australia, Adelaide, SA, Australia., Hahn C; Centre for Cancer Biology, SA Pathology, University of South Australia, Adelaide, SA, Australia., Ellison A; Centre for Genomics and Child Health, Blizard Institute, Queen Mary University of London, London, UK., Tummala H; Centre for Genomics and Child Health, Blizard Institute, Queen Mary University of London, London, UK., Cardoso SR; Centre for Genomics and Child Health, Blizard Institute, Queen Mary University of London, London, UK., Vulliamy T; Centre for Genomics and Child Health, Blizard Institute, Queen Mary University of London, London, UK., Dokal I; Centre for Genomics and Child Health, Blizard Institute, Queen Mary University of London, London, UK., Butler T; Department of Haemato-Oncology, St. Bartholomew's Hospital, Barts Health NHS Trust, London, UK., Smith M; Department of Haemato-Oncology, St. Bartholomew's Hospital, Barts Health NHS Trust, London, UK., Cavenagh J; Department of Haemato-Oncology, St. Bartholomew's Hospital, Barts Health NHS Trust, London, UK., Fitzgibbon J; Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, London, UK. j.fitzgibbon@qmul.ac.uk.

Publikováno v: Leukemia [Leukemia] 2018 Nov; Vol. 32 (11), pp. 2502-2507. Date of Electronic Publication: 2018 Apr 19.

In silico analysis of genes and molecular pathways involved in the pathogenesis of follicular lymphoma.

Autor: Riyadh Abdulwahid, Al-Hasnawi Rasool¹, Mahdi, Mohammed H.², Amiri, Bahareh Shateri³, Koosehlar, Eman⁴, Kazemi, Niloufar⁵, Ghiasi, Fatemeh⁶, Ghobadi, Shaghayegh⁷, Rezaeeyan, Hadi⁵ hadi.rezaeeyan@yahoo.com

Publikováno v: Iranian Journal of Pediatric Hematology & Oncology. 2024, Vol. 14 Issue 3, p205-216. 12p.

Catalog of Differentially Expressed Long Non-Coding RNA following Activation of Human and Mouse Innate Immune Response.

Autor: Roux BT; Department of Pharmacy and Pharmacology, University of Bath, Bath, United Kingdom., Heward JA; Barts Cancer Institute, Queen Mary University of London, London, United Kingdom., Donnelly LE; Airway Disease, National Heart and Lung Institute, Imperial College, London, United Kingdom., Jones SW; Institute of Inflammation and Ageing, MRC-ARUK Centre for Musculoskeletal Ageing Research, University of Birmingham, Birmingham, United Kingdom., Lindsay MA; Department of Pharmacy and Pharmacology, University of Bath, Bath, United Kingdom.; Airway Disease, National Heart and Lung Institute, Imperial College, London, United Kingdom.

Publikováno v: Frontiers in immunology [Front Immunol] 2017 Aug 29; Vol. 8, pp. 1038. Date of Electronic Publication: 2017 Aug 29 (Print Publication: 2017).